{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:28:00Z","timestamp":1791563280287,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This study was supported by a grant from the Cuiying Science and Technology Innovation Program of the Second Hospital of Lanzhou University","award":["NO. CY2024-MS-A02"],"award-info":[{"award-number":["NO. CY2024-MS-A02"]}]},{"name":"This study was supported by a grant from the Cuiying Science and Technology Innovation Program of the Second Hospital of Lanzhou University","award":["No. CY2021-QN-A13"],"award-info":[{"award-number":["No. CY2021-QN-A13"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-03964-4","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T14:19:36Z","timestamp":1752502776000},"page":"265-276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["High FSTL1 expression promotes bladder cancer progression by enhancing tumor cell migration"],"prefix":"10.1007","volume":"28","author":[{"given":"Helin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9622-9664","authenticated-orcid":false,"given":"Panfeng","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"issue":"3","key":"3964_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3964_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40779-025-00599-y","volume":"12","author":"DC Feng","year":"2025","unstructured":"Feng DC, Li DX, Wu RC, Wang J, Xiao YH, Yoo KH, et al. Global burden and cross-country inequalities in urinary tumors from 1990 to 2021 and predicted incidence changes to 2046. Mil Med Res. 2025;12(1):12. https:\/\/doi.org\/10.1186\/s40779-025-00599-y.","journal-title":"Mil Med Res"},{"issue":"11","key":"3964_CR3","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/cac2.12215","volume":"41","author":"ZH Chen","year":"2021","unstructured":"Chen ZH, Lin L, Wu CF, Li CF, Xu RH, Sun Y. Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine. Cancer Commun (London, England). 2021;41(11):1100\u201315. https:\/\/doi.org\/10.1002\/cac2.12215.","journal-title":"Cancer Commun (London, England)"},{"issue":"7","key":"3964_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1158\/2159-8290.Cd-17-1415","volume":"8","author":"TR Rebbeck","year":"2018","unstructured":"Rebbeck TR, Burns-White K, Chan AT, Emmons K, Freedman M, Hunter DJ, et al. Precision prevention and early detection of cancer: fundamental principles. Cancer Discov. 2018;8(7):803\u201311. https:\/\/doi.org\/10.1158\/2159-8290.Cd-17-1415.","journal-title":"Cancer Discov"},{"key":"3964_CR5","doi-asserted-by":"publisher","first-page":"148263","DOI":"10.1016\/j.gene.2024.148263","volume":"906","author":"R Du","year":"2024","unstructured":"Du R, Li K, Guo K, Chen Z, Han L, Bian H. FSTL1: a double-edged sword in cancer development. Gene. 2024;906:148263. https:\/\/doi.org\/10.1016\/j.gene.2024.148263.","journal-title":"Gene"},{"issue":"22","key":"3964_CR6","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1158\/0008-5472.Can-20-4226","volume":"81","author":"JJ Loh","year":"2021","unstructured":"Loh JJ, Li TW, Zhou L, Wong TL, Liu X, Ma VWS, et al. FSTL1 secreted by activated fibroblasts promotes hepatocellular carcinoma metastasis and stemness. Can Res. 2021;81(22):5692\u2013705. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-4226.","journal-title":"Can Res"},{"issue":"24","key":"3964_CR7","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.1158\/0008-5472.Can-19-0842","volume":"79","author":"J Chiou","year":"2019","unstructured":"Chiou J, Chang YC, Tsai HF, Lin YF, Huang MS, Yang CJ, et al. Follistatin-like protein 1 inhibits lung cancer metastasis by preventing proteolytic activation of osteopontin. Can Res. 2019;79(24):6113\u201325. https:\/\/doi.org\/10.1158\/0008-5472.Can-19-0842.","journal-title":"Can Res"},{"key":"3964_CR8","doi-asserted-by":"publisher","first-page":"1793005","DOI":"10.1155\/2022\/1793005","volume":"2022","author":"H Zhao","year":"2022","unstructured":"Zhao H, Chen Z, Fang Y, Su M, Xu Y, Wang Z, et al. Prediction of prognosis and recurrence of bladder cancer by ECM-related genes. J Immunol Res. 2022;2022:1793005. https:\/\/doi.org\/10.1155\/2022\/1793005.","journal-title":"J Immunol Res"},{"issue":"6","key":"3964_CR9","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2147\/j.issn.1000-9604.2023.06.12","volume":"35","author":"Z Tuo","year":"2023","unstructured":"Tuo Z, Feng D, Jiang Z, Bi L, Yang C, Wang Q. Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis. Chin J Cancer Res Chung-kuo yen cheng yen chiu. 2023;35(6):686\u2013701. https:\/\/doi.org\/10.2147\/j.issn.1000-9604.2023.06.12.","journal-title":"Chin J Cancer Res Chung-kuo yen cheng yen chiu"},{"issue":"9","key":"3964_CR10","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1097\/cad.0000000000000396","volume":"27","author":"JF Liu","year":"2016","unstructured":"Liu JF, Li YS, Drew PA, Zhang C. The effect of celecoxib on DNA methylation of CDH13, TFPI2, and FSTL1 in squamous cell carcinoma of the esophagus in vivo. Anticancer Drugs. 2016;27(9):848\u201353. https:\/\/doi.org\/10.1097\/cad.0000000000000396.","journal-title":"Anticancer Drugs"},{"issue":"21","key":"3964_CR11","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.1158\/0008-5472.Can-17-1411","volume":"77","author":"MC Lau","year":"2017","unstructured":"Lau MC, Ng KY, Wong TL, Tong M, Lee TK, Ming XY, et al. FSTL1 promotes metastasis and chemoresistance in esophageal squamous cell carcinoma through NF\u03baB-BMP signaling cross-talk. Can Res. 2017;77(21):5886\u201399. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-1411.","journal-title":"Can Res"},{"key":"3964_CR12","doi-asserted-by":"publisher","DOI":"10.3892\/or.2023.8652","author":"Z Liu","year":"2023","unstructured":"Liu Z, Zhang H, Hu X. Analysis of the expression and mechanism of follistatin-like protein 1 in cervical cancer. Oncol Rep. 2023. https:\/\/doi.org\/10.3892\/or.2023.8652.","journal-title":"Oncol Rep"},{"issue":"3","key":"3964_CR13","first-page":"712","volume":"11","author":"M Wu","year":"2021","unstructured":"Wu M, Ding Y, Wu N, Jiang J, Huang Y, Zhang F, et al. FSTL1 promotes growth and metastasis in gastric cancer by activating AKT related pathway and predicts poor survival. Am J Cancer Res. 2021;11(3):712\u201328.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"3964_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/cbm-170132","volume":"20","author":"W Yang","year":"2017","unstructured":"Yang W, Wu Y, Wang C, Liu Z, Xu M, Zheng X. FSTL1 contributes to tumor progression via attenuating apoptosis in a AKT\/GSK-3\u03b2-dependent manner in hepatocellular carcinoma. Cancer Biomark Sect A Dis Mark. 2017;20(1):75\u201385. https:\/\/doi.org\/10.3233\/cbm-170132.","journal-title":"Cancer Biomark Sect A Dis Mark"},{"issue":"3","key":"3964_CR15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/15384047.2018.1529101","volume":"20","author":"S Cheng","year":"2019","unstructured":"Cheng S, Huang Y, Lou C, He Y, Zhang Y, Zhang Q. FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin \u03b23\/Wnt signaling under miR-137 regulation. Cancer Biol Ther. 2019;20(3):328\u201337. https:\/\/doi.org\/10.1080\/15384047.2018.1529101.","journal-title":"Cancer Biol Ther"},{"key":"3964_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107302","volume":"206","author":"Z Tuo","year":"2024","unstructured":"Tuo Z, Zhang Y, Li D, Wang Y, Wu R, Wang J, et al. Relationship between clonal evolution and drug resistance in bladder cancer: a genomic research review. Pharmacol Res. 2024;206: 107302. https:\/\/doi.org\/10.1016\/j.phrs.2024.107302.","journal-title":"Pharmacol Res"},{"issue":"8","key":"3964_CR17","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/cbf.3227","volume":"34","author":"H Wang","year":"2016","unstructured":"Wang H, Wu S, Huang S, Yin S, Zou G, Huang K, et al. Follistatin-like protein 1 contributes to dendritic cell and T-lymphocyte activation in nasopharyngeal carcinoma patients by altering nuclear factor \u03bab and Jun N-terminal kinase expression. Cell Biochem Funct. 2016;34(8):554\u201362. https:\/\/doi.org\/10.1002\/cbf.3227.","journal-title":"Cell Biochem Funct"},{"key":"3964_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ircmb.2019.07.004","volume":"348","author":"S Balan","year":"2019","unstructured":"Balan S, Saxena M, Bhardwaj N. Dendritic cell subsets and locations. Int Rev Cell Mol Biol. 2019;348:1\u201368. https:\/\/doi.org\/10.1016\/bs.ircmb.2019.07.004.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"1","key":"3964_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-020-00939-6","volume":"13","author":"Y Wang","year":"2020","unstructured":"Wang Y, Xiang Y, Xin VW, Wang XW, Peng XC, Liu XQ, et al. Dendritic cell biology and its role in tumor immunotherapy. J Hematol Oncol. 2020;13(1):107. https:\/\/doi.org\/10.1186\/s13045-020-00939-6.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"3964_CR20","doi-asserted-by":"publisher","first-page":"7211","DOI":"10.18632\/aging.202579","volume":"13","author":"J Ma","year":"2021","unstructured":"Ma J, Yang Y, Wang L, Jia X, Lu T, Zeng Y, et al. Follistatin-like 1 deficiency impairs T cell development to promote lung metastasis of triple negative breast cancer. Aging. 2021;13(5):7211\u201327. https:\/\/doi.org\/10.18632\/aging.202579.","journal-title":"Aging"},{"key":"3964_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13101724","author":"Y Yang","year":"2023","unstructured":"Yang Y, Lu T, Jia X, Gao Y. FSTL1 suppresses triple-negative breast cancer lung metastasis by inhibiting M2-like tumor-associated macrophage recruitment toward the lungs. Diagnostics (Basel, Switzerland). 2023. https:\/\/doi.org\/10.3390\/diagnostics13101724.","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"3964_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102923","volume":"67","author":"L Yao","year":"2023","unstructured":"Yao L, Hou J, Wu X, Lu Y, Jin Z, Yu Z, et al. Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation. Redox Biol. 2023;67: 102923. https:\/\/doi.org\/10.1016\/j.redox.2023.102923.","journal-title":"Redox Biol"},{"key":"3964_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215690","volume":"537","author":"Y Ogiwara","year":"2022","unstructured":"Ogiwara Y, Nakagawa M, Nakatani F, Uemura Y, Zhang R, Kudo-Saito C. Blocking FSTL1 boosts NK immunity in treatment of osteosarcoma. Cancer Lett. 2022;537: 215690. https:\/\/doi.org\/10.1016\/j.canlet.2022.215690.","journal-title":"Cancer Lett"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-03964-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-03964-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-03964-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T21:02:49Z","timestamp":1768165369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-03964-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3964"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-03964-4","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflict of interest was reported by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All participants provided informed consent prior to their participation. This study received the Lanzhou University Second Hospital Ethical Committee approval. Project No. 2025A-679.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}}]}}